The Ritedose Corporation: Drug Recall
Recall #D-0946-2023 · 07/21/2023
Class II: Risk
Recall Details
- Recall Number
- D-0946-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- The Ritedose Corporation
- Status
- Completed
- Date Initiated
- 07/21/2023
- Location
- Columbia, SC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 44 cartons
Reason for Recall
CGMP deviation: product released prior to supplier approval.
Product Description
Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96.
Distribution Pattern
Nationwide in the US
Other Recalls by The Ritedose Corporation
- Class III: Low Risk 04/01/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.